Abstract

1456P - Phase IV, open-label, multicentre trial of afatinib in patients (pts) aged ≥70 yrs with NSCLC harbouring common (Del19/L858R) EGFR mutations: Preliminary results

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer.
Oscar Arrieta ... Luis Corrales
Lung cancer (Amsterdam, Netherlands) | VOL. 87
Oscar Arrieta, et. al.Oscar Arrieta ... Luis Corrales
18 Dec 2014
187P - Common and Rare Egfr Mutations in Non-Small Cell Lung Cancer
A.D Campos Parra ... O Arrieta
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 25
A.D Campos Parra, et. al.A.D Campos Parra ... O Arrieta
01 Sep 2014
Efficacy of Gefitinib in Patients with Advanced Non-small-cell Carcinoma of the Lung Harboring Common, Uncommon and Complex EGFR Mutations
Wang Chun Kwok ... Mary Sau Man Ip
Clinical cancer drugs | VOL. 8
Wang Chun Kwok, et. al.Wang Chun Kwok ... Mary Sau Man Ip
01 Sep 2021
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations
Gee-Chen Chang ... Keunchil Park
International Journal of Clinical Oncology | VOL. 26
Gee-Chen Chang, et. al.Gee-Chen Chang ... Keunchil Park
30 Mar 2021
View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title
Journal
Date
Author
Efficacy of TIL Therapy in Advanced Cutaneous Melanoma in the Current Immuno-oncology Era: Updated Systematic Review and Meta-analysis
S Martín-Lluesma ... G Coukos
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
S Martín-Lluesma, et. al.S Martín-Lluesma ... G Coukos
23 Jul 2024
Exploiting the tumor microenvironment and tumor mechanobiology for the treatment of cancer cachexia
Kostas A Papavassiliou ... Athanasios G Papavassiliou
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
Kostas A Papavassiliou, et. al.Kostas A Papavassiliou ... Athanasios G Papavassiliou
23 Jul 2024
Immune Checkpoint Inhibitors in Endometrial Cancer: A Cinderella Story
N Colombo ... M Jalving
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
N Colombo, et. al.N Colombo ... M Jalving
22 Jul 2024
Overall survival in first-line HR+/HER2- advanced breast cancer in the era of CDK4/6 inhibitors
Rodrigo Sánchez-Bayona ... Mafalda Oliveira
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
Rodrigo Sánchez-Bayona, et. al.Rodrigo Sánchez-Bayona ... Mafalda Oliveira
22 Jul 2024
View more papers